At a time when Thailand's economy faces multiple challenges, an often overlooked risk is the "obesity crisis," recently highlighted. Bumrungrad Hospital Public Company Limited (BH) revealed alarming data that nearly 50% of Thais are overweight.
This issue is not merely a health problem for Thai people but a ticking time bomb eroding GDP, potentially causing economic damage up to 5.6 trillion baht if left unaddressed. It is a major challenge directly impacting the country's structure.
Yet, within every crisis lies opportunity. In this case, the key leader, Dr. Athirat Jarukitpipat, CEO of BH, has strategized to develop the VitalLife health promotion center as a spearhead to transform this healthcare crisis into a promising new S-Curve growth path.
Regarding investor concerns about "Copay" insurance, management firmly states the impact is minimal due to a well-diversified customer base, as reflected in the stock price recovery that signals renewed confidence.
joint assessments by the World Health Organization (WHO) and the World Obesity Federation (WOF) highlight the economic losses caused by obesity in Thailand.
In 2019 alone, Thailand lost an estimated 8.27 billion U.S. dollars, or about 256.37 billion baht, equivalent to 1.5% of GDP, averaging a loss of 4,000 baht per person.
More concerning is the future outlook: reports predict that without urgent action, by 2060 (34 years ahead), the economic impact will worsen 22-fold from 2019 levels.
Damages could reach 180.78 billion U.S. dollars, or roughly 5.6 trillion baht, accounting for as much as 5.6% of Thailand's future GDP.
These economic losses stem from direct medical costs and indirect costs such as reduced work productivity, absenteeism, underperformance, and premature death, all negatively affecting the country's growth potential.
Dr. Athirat Jarukitpipat, CEO of Bumrungrad Hospital, reflected on the current situation citing data from the Department of Health, Ministry of Public Health, showing that 42.4% of Thais aged 15 and older are overweight or obese, aligning with global trends predicting over 1 billion people worldwide will face obesity by 2030.
Being overweight is not just about appearance but a gateway to serious non-communicable diseases (NCDs) such as diabetes, hypertension, cardiovascular disease, fatty liver, and certain cancers, which incur long-term costs.
To address this crisis, weight management is not merely a beauty trend but an urgent health priority. Bumrungrad Hospital has adopted a holistic treatment approach focusing on sustainable root-cause solutions through specialist medical teams and multidisciplinary professionals.
A key highlight is applying medical innovations to enhance treatment effectiveness, including endoscopic gastric suturing, combining medication with behavioral modification, and personalized treatment design.
Dr. Athirat added that, in terms of business opportunities from the well-being and weight loss trend, Bumrungrad has integrated the VitalLife health promotion center seamlessly with the hospital, emphasizing holistic care including lifestyle adjustment, nutrition, and screening to provide appropriate treatment referrals.
The well-being trend covers both physical and mental health, representing a high-growth potential market. Currently, VitalLife generates revenue in the billion-baht range and aims to reach 2 billion baht by focusing on world-class quality standards to attract wellness tourism to Thailand.
Regarding concerns about life insurance co-payment policies potentially affecting hospitals, Dr. Athirat and management assured that the impact on BH is minimal and not significant, as insured patients comprise no more than 30% of the hospital's customers, evenly split between foreign and Thai insurance holders, providing good risk diversification.
Management pointed out that the stock price decline was only a short-term reaction to news, with prices bouncing back to previous levels within a week, reflecting a strong business foundation and investor confidence.
As for performance outlook, despite seasonal effects such as Ramadan in Q1, the number of foreign patients has not decreased, with positive factors expected from the recovery of Middle Eastern patients, especially with anticipated MOUs between the Thai and Saudi Arabian governments, and the return of Kuwaiti patients as their domestic situation stabilizes.
For more stock and investment news, visit Thairath Money at
Follow the Facebook page Thairath Money at this link